Press release
Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth Driver: A Major Catalyst in the Evolution of the Flow Cytometry In Oncology And Immunology Market in 2025
Flow Cytometry In Oncology And Immunology Market
The escalating incidence of cancer is predicted to stimulate the advancement of flow cytometry in the oncology and immunology sector. Cancer, a term encapsulating a range of conditions characterized by unchecked proliferation and dispersion of abnormal body cells, is a key area of application for flow cytometry, particularly within oncology and immunology studies examining cancer and immune cells. For instance, in October 2022, Macmillan Cancer Support, a health charity based in the UK, reported that 3 million individuals were affected by cancer in 2020, with projections suggesting an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As such, the surge in cancer incidence is instrumental in fueling the growth of flow cytometry in the oncology and immunology markets.
Get Your Flow Cytometry In Oncology And Immunology Market Report Here:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report
How will the growth rate of the flow cytometry in oncology and immunology market shape industry trends by 2034?
The market size for flow cytometry in oncology and immunology has experienced swift growth in the past few years. Forecasts anticipate a jump from $2.11 billion in 2024 to $2.33 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. The growth during the historical period is linked to progress in cancer research, an expansion in immunology research, advances in diagnostic applications, an increase in autoimmune diseases, along with developments in drugs and clinical trials.
In the forthcoming years, the market size for flow cytometry in oncology and immunology is predicted to experience substantial growth. The market is projected to expand to $3.46 billion by 2029, with a compound annual growth rate (CAGR) of 10.4%. Factors resulting in this growth during the forecast period include integration with genomics and proteomics, an increase in the usage of single-cell analysis, growing applications in infectious diseases, an increase in cancer cases, and the introduction of point-of-care flow cytometry. Key tendencies in this forecast period encompassing immunophenotyping for immunotherapy, miniaturization of flow cytometry systems, multiparametric analysis, transitioning towards spectral flow cytometry, and cooperative research endeavors.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp
What trends are poised to drive the future success of the flow cytometry in oncology and immunology market?
Innovations in technology are emerging as a significant trend in the oncology and immunology flow cytometry market. To maintain their market foothold, leading companies active in this sector are embracing these new technologies. For example, Becton Dickinson, a medical technology firm based in the US, introduced the BD Research Cloud for oncology and immunology flow cytometry in September 2022. The BD Cloud, a cloud-based software system, simplifies the flow cytometry process for research professionals working in fields like immunology, virology, infectious disease, and oncology surveillance, promoting more efficient and high-quality studies. Becton Dickinson is utilizing cutting-edge technologies, including the BD Horizon RealYellow and RealBlue Reagents and the newly launched BD FACSDiscover S8 Cell Sorter equipped with BD CellView Image Technology. These tools enhance flow cytometry capabilities and provide researchers with the resources necessary to further their significant studies. Designed on a standard cloud infrastructure, the BD Research Cloud is especially compatible with BD equipment and reagents.
Which primary segments of the flow cytometry in oncology and immunology market are driving growth and industry transformations?
The flow cytometry in oncology and immunology market covered in this report is segmented -
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469
Which geographical regions are pioneering growth in the flow cytometry in oncology and immunology market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the flow cytometry in oncology and immunology market landscape?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp
What Is Covered In The Flow Cytometry In Oncology And Immunology Global Market Report?
• Market Size Forecast: Examine the flow cytometry in oncology and immunology market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the flow cytometry in oncology and immunology market for a structured understanding.
• Key Players Overview: Analyze major players in the flow cytometry in oncology and immunology market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the flow cytometry in oncology and immunology market.
• Segment Contributions: Evaluate how different segments drive overall growth in the flow cytometry in oncology and immunology market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the flow cytometry in oncology and immunology market.
• Industry Challenges: Identify potential risks and obstacles affecting the flow cytometry in oncology and immunology market.
• Competitive Landscape: Review strategic developments in the flow cytometry in oncology and immunology market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth Driver: A Major Catalyst in the Evolution of the Flow Cytometry In Oncology And Immunology Market in 2025 here
News-ID: 3896356 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
